The Pfizer-BioNTech COVID-19 vaccine appears to be effective against 16 mutations found in new coronavirus variants, according to preliminary data from a study.
The Associated Press is reporting that the study, conducted by Pfizer and University of Texas researchers, found that the vaccine appeared to work against N501Y, a mutation found in new variants from the United Kingdom and South Africa, in lab tests, the AP reported.
The study, which has not yet been peer-reviewed, also found that the vaccine seemed to protect against 15 other mutations, according to the AP. However, researchers have not yet tested the vaccine’s effectiveness against E484K, an additional mutation found in one of the South African variants, the news agency reported.
– The Associated Press contributed to this report.
More coronavirus pandemic coverage: